The escalating conflict between North and South Korea exacerbated global economic recovery concerns to send the markets tumbling during the midday with the Dow plunging 196 points to 9870. Nasdaq stumbled 44 points to 2169.
On the upside
The Food and Drug Adminstration approved Genzyme's (Nasdaq: GENZ) late-onset Pompe disease treatment Lumizyme.
Capstone Turbine (Nasdaq: CPST) introduced its CR200 Medium Btu microturbine product that meets the most stringent global emission requirements.
Dynegy (NYSE: DYN) entered a new $150 million credit facility with Morgan Stanley Capital Group.
On the downside
